Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Effects of statins on bone mineral density: a meta-analysis of clinical studies.

Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY.

Bone. 2007 Jun;40(6):1581-7. Epub 2007 Mar 1.

PMID:
17409043
[PubMed - indexed for MEDLINE]
2.

Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.

Hatzigeorgiou C, Jackson JL.

Osteoporos Int. 2005 Aug;16(8):990-8. Epub 2005 Mar 3. Review.

PMID:
15744453
[PubMed - indexed for MEDLINE]
3.

Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.

Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Ensrud KE, van der Klift M, Pols HA.

Arch Intern Med. 2004 Jan 26;164(2):146-52.

PMID:
14744837
[PubMed - indexed for MEDLINE]
4.

HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.

Liu J, Zhu LP, Yang XL, Huang HL, Ye DQ.

Bone. 2013 May;54(1):151-6. doi: 10.1016/j.bone.2013.01.044. Epub 2013 Feb 4.

PMID:
23388418
[PubMed - indexed for MEDLINE]
5.

Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.

Martyn-St James M, Carroll S.

Bone. 2008 Sep;43(3):521-31. doi: 10.1016/j.bone.2008.05.012. Epub 2008 May 26.

PMID:
18602880
[PubMed - indexed for MEDLINE]
6.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
7.

Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.

Chuengsamarn S, Rattanamongkoulgul S, Suwanwalaikorn S, Wattanasirichaigoon S, Kaufman L.

Bone. 2010 Apr;46(4):1011-5. doi: 10.1016/j.bone.2009.12.023. Epub 2010 Jan 4.

PMID:
20045497
[PubMed - indexed for MEDLINE]
8.

Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density.

De Leo V, Morgante G, la Marca A, Lanzetta D, Cobellis L, Petraglia F.

Gynecol Endocrinol. 2003 Aug;17(4):329-32.

PMID:
14503978
[PubMed - indexed for MEDLINE]
9.

Statins and osteoporosis: a clinical review.

Gonyeau MJ.

Pharmacotherapy. 2005 Feb;25(2):228-43. Review.

PMID:
15767237
[PubMed - indexed for MEDLINE]
10.

Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density.

Funkhouser HL, Adera T, Adler RA.

J Clin Densitom. 2002 Summer;5(2):151-8.

PMID:
12110758
[PubMed - indexed for MEDLINE]
11.

Statins: under investigation for increasing bone mineral density and augmenting fracture healing.

Tang QO, Tran GT, Gamie Z, Graham S, Tsialogiannis E, Tsiridis E, Linder T, Tsiridis E.

Expert Opin Investig Drugs. 2008 Oct;17(10):1435-63. doi: 10.1517/13543784.17.10.1435 . Review.

PMID:
18808306
[PubMed - indexed for MEDLINE]
12.

HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?

Schlienger RG, Meier CR.

Drugs Aging. 2003;20(5):321-36. Review.

PMID:
12696993
[PubMed - indexed for MEDLINE]
13.

High-intensity resistance training and postmenopausal bone loss: a meta-analysis.

Martyn-St James M, Carroll S.

Osteoporos Int. 2006;17(8):1225-40. Epub 2006 Jun 1.

PMID:
16823548
[PubMed - indexed for MEDLINE]
14.

HMG CoA reductase inhibitors and the skeleton: a comprehensive review.

Bauer DC.

Osteoporos Int. 2003 Jun;14(4):273-82. Epub 2003 May 8. Review.

PMID:
12736772
[PubMed - indexed for MEDLINE]
15.

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

Clin Ther. 2007 Sep;29(9):1937-49.

PMID:
18035193
[PubMed - indexed for MEDLINE]
16.

Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.

Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Bianchi G.

Nephrol Dial Transplant. 2009 May;24(5):1472-7. doi: 10.1093/ndt/gfn690. Epub 2008 Dec 15.

PMID:
19075192
[PubMed - indexed for MEDLINE]
Free Article
17.

Statins and bone metabolism.

Horiuchi N, Maeda T.

Oral Dis. 2006 Mar;12(2):85-101. Review.

PMID:
16476028
[PubMed - indexed for MEDLINE]
18.

Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials.

Yue J, Zhang X, Dong B, Yang M.

Menopause. 2010 Sep-Oct;17(5):1071-9. doi: 10.1097/gme.0b013e3181d3e036. Review.

PMID:
20473231
[PubMed - indexed for MEDLINE]
19.

Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management.

Coons JC.

Ann Pharmacother. 2002 Feb;36(2):326-30. Review.

PMID:
11847956
[PubMed - indexed for MEDLINE]
20.

Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus.

Safaei H, Janghorbani M, Aminorroaya A, Amini M.

Acta Diabetol. 2007 Jun;44(2):76-82. Epub 2007 May 27.

PMID:
17530471
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk